# Jefferson Capital, Inc. / DE: financial statements, quarterly

JCAP · Nasdaq · CIK 2046042 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/jcap.md) · [Financials](/companies/jcap/financials.md) · [Filings](/companies/jcap/filings.md) · [Insiders](/companies/jcap/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/jcap/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [104](/filings/0001558370-25-011577.md) | [111](/filings/0001104659-25-112518.md) | [119 d](/filings/0001104659-26-027199.md) | [155](/filings/0001104659-26-061206.md) | [153](/filings/0001104659-26-095946.md) | [151](/filings/0001104659-25-112518.md) | [155 d](/filings/0001104659-26-027199.md) | [176](/filings/0001104659-26-061206.md) | [178](/filings/0001104659-26-095946.md) |
| Operating income | $m | [55.1](/filings/0001558370-25-011577.md) | [59.4](/filings/0001104659-25-112518.md) | [53.8 d](/filings/0001104659-26-027199.md) | [89.3](/filings/0001104659-26-061206.md) | [86.6](/filings/0001104659-26-095946.md) | [70.0](/filings/0001104659-25-112518.md) | [70.6 d](/filings/0001104659-26-027199.md) | [80.2](/filings/0001104659-26-061206.md) | [81.4](/filings/0001104659-26-095946.md) |
| Interest expense | $m | [18.2](/filings/0001558370-25-011577.md) | [19.8](/filings/0001104659-25-112518.md) | [22.1 d](/filings/0001104659-26-027199.md) | [24.8](/filings/0001104659-26-061206.md) | [25.8](/filings/0001104659-26-095946.md) | [26.5](/filings/0001104659-25-112518.md) | [28.6 d](/filings/0001104659-26-027199.md) | [30.6](/filings/0001104659-26-061206.md) | [30.4](/filings/0001104659-26-095946.md) |
| Income tax | $m | [1.9](/filings/0001558370-25-011577.md) | [2.4](/filings/0001104659-25-112518.md) | [2.5 d](/filings/0001104659-26-027199.md) | [2.7](/filings/0001104659-26-061206.md) | [14.3](/filings/0001104659-26-095946.md) | [7.2](/filings/0001104659-25-112518.md) | [6.4 d](/filings/0001104659-26-027199.md) | [13.4](/filings/0001104659-26-061206.md) | [12.0](/filings/0001104659-26-095946.md) |
| Net income | $m | [32.2](/filings/0001558370-25-011577.md) | [36.9](/filings/0001104659-25-112518.md) | [27.0 d](/filings/0001104659-26-027199.md) | [64.2](/filings/0001104659-26-061206.md) | [47.7](/filings/0001104659-26-095946.md) | [38.4](/filings/0001104659-25-112518.md) | [37.7 d](/filings/0001104659-26-027199.md) | [37.6](/filings/0001104659-26-061206.md) | [41.3](/filings/0001104659-26-095946.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | [16.76](/filings/0001104659-26-095946.md) | [0.59](/filings/0001104659-25-112518.md) | not reported | [0.61](/filings/0001104659-26-061206.md) | [0.67](/filings/0001104659-26-095946.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | [18.61](/filings/0001104659-26-095946.md) | [0.59](/filings/0001104659-25-112518.md) | not reported | [0.61](/filings/0001104659-26-061206.md) | [0.67](/filings/0001104659-26-095946.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [14.4](/filings/0001104659-26-027199.md) | not reported | [10.5](/filings/0001558370-25-011577.md) | [18.3](/filings/0001104659-25-112518.md) | [35.5](/filings/0001104659-26-027199.md) | [27.0](/filings/0001104659-26-061206.md) | [51.7](/filings/0001104659-26-095946.md) | [42.3](/filings/0001104659-25-112518.md) | [23.2](/filings/0001104659-26-095946.md) | [26.2](/filings/0001104659-26-061206.md) | [20.4](/filings/0001104659-26-095946.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | not reported | [1,654](/filings/0001104659-26-027199.md) | not reported | [1,768](/filings/0001558370-25-011577.md) | [1,803](/filings/0001104659-25-112518.md) | [2,087](/filings/0001104659-26-095946.md) | [2,084](/filings/0001104659-26-061206.md) | [2,084](/filings/0001104659-26-095946.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | [1,272](/filings/0001104659-26-027199.md) | not reported | [1,357](/filings/0001558370-25-011577.md) | [1,366](/filings/0001104659-25-112518.md) | [1,611](/filings/0001104659-26-095946.md) | [1,641](/filings/0001104659-26-061206.md) | [1,608](/filings/0001104659-26-095946.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1,754](/filings/0001104659-26-027199.md) | not reported | not reported |
| Shareholders' equity | $m | [215](/filings/0001104659-26-027199.md) | [304](/filings/0001104659-26-027199.md) | [334](/filings/0001558370-25-011577.md) | [363](/filings/0001104659-25-112518.md) | [384](/filings/0001104659-25-112518.md) | [383](/filings/0001104659-26-095946.md) | [435](/filings/0001104659-26-095946.md) | [411](/filings/0001104659-26-095946.md) | [437](/filings/0001104659-25-112518.md) | [476](/filings/0001104659-26-095946.md) | [443](/filings/0001104659-26-095946.md) | [476](/filings/0001104659-26-095946.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.7 d](/filings/0001104659-25-112518.md) | [77.4 d](/filings/0001104659-26-027199.md) | [51.7](/filings/0001104659-26-061206.md) | [78.9 d](/filings/0001104659-26-095946.md) | [63.1 d](/filings/0001104659-25-112518.md) | [75.2 d](/filings/0001104659-26-027199.md) | [39.6](/filings/0001104659-26-061206.md) | [43.3 d](/filings/0001104659-26-095946.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001104659-25-112518.md) | not reported | not reported | not reported | [0.1 d](/filings/0001104659-25-112518.md) | not reported | not reported | not reported |
| Dividends paid | $m | [20.0 d](/filings/0001104659-25-112518.md) | [16.0 d](/filings/0001104659-26-027199.md) | [16.0](/filings/0001104659-26-061206.md) | [16.4 d](/filings/0001104659-26-095946.md) | [15.5 d](/filings/0001104659-25-112518.md) | [15.5 d](/filings/0001104659-26-027199.md) | [0.0](/filings/0001104659-26-061206.md) | [29.6 d](/filings/0001104659-26-095946.md) |
| Share repurchases | $m | not reported | not reported | [0.0](/filings/0001104659-26-061206.md) | [0.0 d](/filings/0001104659-26-095946.md) | not reported | not reported | [58.9](/filings/0001104659-26-061206.md) | [0.0 d](/filings/0001104659-26-095946.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [2.8](/filings/0001104659-26-095946.md) | [58.3](/filings/0001104659-25-112518.md) | [55.6](/filings/0001104659-26-061206.md) | [55.5](/filings/0001104659-26-095946.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 57,425,536 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001104659-26-095946.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.